<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">44533553X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142753.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20111001xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1245/s10434-011-1728-x</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1245/s10434-011-1728-x</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Summary of Prognostic Factors and Patient Selection for Extrapleural Pneumonectomy in the Treatment of Malignant Pleural Mesothelioma</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Christopher Cao, Tristan Yan, Paul Bannon, Brian McCaughan]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: Extrapleural pneumonectomy (EPP) has been shown to improve long-term survival outcomes in selected patients with malignant pleural mesothelioma (MPM). The present study aimed to evaluate potential prognostic factors on overall survival for patients who underwent EPP for MPM and to examine the patient selection process in major referral centers that perform EPP. Methods: A systematic review of the current literature was performed using 5 electronic databases. Relevant studies with prognostic data on overall survival for patients with MPM treated by EPP were included for review. Two reviewers independently assessed each included study. Results: A total of 17 studies from 13 institutions containing the most updated and complete data on prognostic factors for patients with MPM who underwent EPP were included for review. A number of quantitative, clinical, and treatment-related factors were identified to have significant impact on overall survival. Conclusions: Patients with nonepithelial MPM and nodal involvement have consistently demonstrated to have a worse prognosis after EPP. Their eligibility as candidates for EPP should be questioned. The preoperative patient selection process currently differs greatly between institutions and should focus on identifying patients with nonepithelial histologic subtypes and nodal involvement to exclude them as EPP surgical candidates in the future.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Society of Surgical Oncology, 2011</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Cao</subfield>
   <subfield code="D">Christopher</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yan</subfield>
   <subfield code="D">Tristan</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bannon</subfield>
   <subfield code="D">Paul</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">McCaughan</subfield>
   <subfield code="D">Brian</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/10(2011-10-01), 2973-2979</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:10&lt;2973</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1245/s10434-011-1728-x</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1245/s10434-011-1728-x</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Cao</subfield>
   <subfield code="D">Christopher</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yan</subfield>
   <subfield code="D">Tristan</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bannon</subfield>
   <subfield code="D">Paul</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">McCaughan</subfield>
   <subfield code="D">Brian</subfield>
   <subfield code="u">The Systematic Review Group, The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Annals of Surgical Oncology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">18/10(2011-10-01), 2973-2979</subfield>
   <subfield code="x">1068-9265</subfield>
   <subfield code="q">18:10&lt;2973</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">18</subfield>
   <subfield code="o">10434</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
